Joint Commission Survey Update
In June , the Joint Commission , who accredits our facilities for the Centers for Medicare & Medicaid Services , arrived at Renown Regional Medical Center to survey the hospital and Renown Home Health & Hospice . At a June Renown Employee Forum , Dr . Brian Erling announced that both Renown Regional and Home Health passed with flying colors .
“ The Joint Commission provided lots of areas for improvements – that ' s their job – but we had zero condition-level findings ,” said Dr . Erling . “ This means that we had no serious issues , especially regarding our participation with Medicare . Kudos to everyone on those teams !”
Surgical Oncology Team Amongst the First to Use Histosonics ' to Deliver Non-invasive , Personalized Treatments for Patients with Liver Tumors
The first patients at Renown have received targeted liver tumor treatments through the Edison ® System histotripsy technology , which uses focused ultrasound waves to noninvasively destroy a designated tissue or tumor in the liver . This revolutionary technology represents a significant advancement in providing leading-edge surgical care to patients . Renown Health is one of the first organizations on the West Coast , and the only healthcare organization in Nevada , to offer this revolutionary non-invasive clinical procedure .
Surgical oncologists Christos A . Galanopoulos MD , MBA , MSc , FACS ; Nicholas Manguso , MD ; and Randy Zuckerman , MD at the William N . Pennington Cancer Institute , join colleagues from the Mayo Clinic , Cleveland Clinic and Johns Hopkins Medical Center in being amongst the first physicians in the world trained to perform the procedure which destroys both primary and metastatic liver tumors , including those that can ’ t otherwise be removed surgically .
Thanks to a private donation , Renown ’ s Surgical Oncology team is amongst the first to use HistoSonics ' image guided histotripsy system .
9